TransMedics Group/TMDX

$84.16

-6%
-
1D1W1MYTD1YMAX

About TransMedics Group

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

Ticker

TMDX

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Waleed Hassanein

Employees

584

Headquarters

Andover, United States

TMDX Metrics

BasicAdvanced
$2.76B
Market cap
-
P/E ratio
-$0.77
EPS
1.89
Beta
-
Dividend rate
$2.76B
1.8892
$99.63
$36.42
730K
9.296
8.491
368.948
368.948
-5.09%
-15.42%
-5.53%
11.442
20.04
22.504
158.53%
38.28%
111.23%

What the Analysts think about TMDX

Analyst Ratings

Majority rating from 7 analysts.
Buy

Price Targets

Average projection from 5 analysts.
18.11% upside
High $105.00
Low $95.00
$84.16
Current price
$99.40
Average price target

TMDX Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
4.93% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$81.1M
22.14%
Net income
$4M
-115.75%
Profit margin
4.93%
-112.89%

TMDX Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 500%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.08
-$0.03
-$0.78
$0.12
-
Expected
-$0.25
-$0.13
-$0.16
-$0.03
-$0.05
Surprise
-67.48%
-76.92%
382.47%
-500%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for TransMedics Group stock?

TransMedics Group (TMDX) has a market cap of $2.76B as of April 22, 2024.

What is the P/E ratio for TransMedics Group stock?

The price to earnings (P/E) ratio for TransMedics Group (TMDX) stock is 0 as of April 22, 2024.

Does TransMedics Group stock pay dividends?

No, TransMedics Group (TMDX) stock does not pay dividends to its shareholders as of April 22, 2024.

When is the next TransMedics Group dividend payment date?

TransMedics Group (TMDX) stock does not pay dividends to its shareholders.

What is the beta indicator for TransMedics Group?

TransMedics Group (TMDX) has a beta rating of 1.89. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the TransMedics Group stock price target?

The target price for TransMedics Group (TMDX) stock is $99.4, which is 18.11% above the current price of $84.16. This is an average based on projections from 5 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell TransMedics Group stock

Buy or sell TransMedics Group stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing